Vanda PharmaceuticalsVNDA
那斯達克 · USD
5.25
-0.08
(-1.50%)
收盤 09/10 03:59 (UTC+8)
09/10 03:59 (UTC+8)
Vanda PharmaceuticalsVNDA
5.25
-0.08
(-1.50%)
財務數據
損益表
- 0.47
- 0.50
- 0.48
- 0.53
- 0.50
- 0.53
- 0.56
- 0.57
- 0.52
- 0.51
- 4.84
- 6.35
- -5.59
- 11.61
- -5.91
- 5.09
- 6.97
- 1.70
- -9.61
- -2.30
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 50,529 | 51,718 | 57,216 | 56,258 | 52,590 | 50,041 | 53,185 | 47,651 | 50,474 | 47,462 |
營業成本 | 3,560 | 3,159 | 3,833 | 2,954 | 2,736 | 3,521 | 2,590 | 2,551 | 2,733 | 3,440 |
營業毛利 | 46,969 | 48,559 | 53,383 | 53,304 | 49,854 | 46,520 | 50,595 | 45,100 | 47,741 | 44,022 |
營業費用 | 110,778 | 98,783 | 93,736 | 84,588 | 88,357 | 87,548 | 60,874 | 56,100 | 57,887 | - |
研發費用 | 36,953 | 28,435 | 29,006 | 22,563 | 21,990 | 35,712 | 19,840 | 16,776 | 16,661 | 21,154 |
推銷及管理費用 | 71,838 | 68,361 | 62,978 | 60,273 | 64,616 | 50,084 | 39,282 | 37,573 | 39,474 | 30,085 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 1,987 | 1,987 | 1,752 | 1,752 | 1,751 | 1,752 | 1,752 | 1,751 | 1,752 | 2,018 |
營業利益 | -63,809 | -50,224 | -40,353 | -31,284 | -38,503 | -41,028 | -10,279 | -11,000 | -10,146 | -9,235 |
其他收入及費用 | 1,425 | 1,800 | 2,351 | 2,894 | 3,616 | 3,660 | 3,782 | 4,756 | 4,630 | 4,571 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -62,384 | -48,424 | -38,002 | -28,390 | -34,887 | -37,368 | -6,497 | -6,244 | -5,516 | -4,664 |
所得稅 | 129 | 143 | 103,185 | -5,804 | -7,680 | -7,874 | -1,585 | -920 | -998 | -518 |
稅後純益 | -62,513 | -48,567 | -141,187 | -22,586 | -27,207 | -29,494 | -4,912 | -5,324 | -4,518 | -4,146 |
基本每股稅後盈餘(元) | -1.04 | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 | -0.08 | -0.07 |
稀釋每股稅後盈餘(元) | -1.04 | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.09 | -0.09 | -0.08 | -0.07 |
基本平均股數(千股) | 60226.00 | 59459.00 | 59098.00 | 59091.00 | 58993.00 | 58527.00 | 58308.00 | 58261.00 | 58220.00 | 57760.00 |
稀釋平均股數(千股) | 60226.00 | 59459.00 | 59098.00 | 59091.00 | 58993.00 | 58527.00 | 58308.00 | 58261.00 | 58220.00 | 57760.00 |
還原基本每股稅後盈餘(元) | -1.04 | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.08 | -0.09 | -0.08 | -0.07 |
還原稀釋每股稅後盈餘(元) | -1.04 | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.09 | -0.09 | -0.08 | -0.07 |
還原基本平均股數(千股) | 60,226 | 59,459 | 59,098 | 59,091 | 58,993 | 58,527 | 58,308 | 58,261 | 58,220 | 57,760 |
還原稀釋平均股數(千股) | 60,226 | 59,459 | 59,098 | 59,091 | 58,993 | 58,527 | 58,308 | 58,261 | 58,220 | 57,760 |
EBITDA(千元) | -58,719 | -45,033 | -32,395 | -28,548 | -34,267 | -36,134 | -6,039 | -6,254 | -5,584 | -3,906 |